Dishman Pharmaceuticals and Chemicals sales for FY 2012 rose 9% to $208m although profits fell 29% to $10m. The Carbogen Amcis business reported a Q4 turnover of $77m with a loss of $3m although the company expects the unit to grow significantly in terms of topline and bottomline in its 2013 year.
Money Control
Wednesday 16 May 2012
Carbogen Amcis drags on Dishman
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment